retatrutide heart issues experimental weight-loss drug side effects and concerns Retatrutide Side Effects: What Clinical

For patients using licensed injectable GLP-1 receptor agonists who have concerns about their treatment, contact your GP or diabetes care team for advice

Jun 9, 2026 Jun 9, 2026 7 min You hit your goal weight

The clinical trial data showed that using a lower starting dose (2 mg vs 4 mg initial) significantly reduced the incidence and severity of these symptoms

This prevents the hesitation and start-stop pattern that makes insertions more painful

clinician determines final eligibility Who shouldn't apply: Personal or family history of medullary thyroid carcinoma or MEN 2 syndrome, history of pancreatitis, certain severe GI or kidney conditions, pregnancy, or breastfeeding - clinician screens at intake FDA regulatory status as of June 2026: Active enforcement and regulatory change ongoing